abstract |
The present invention relates to an iontophoresis device and a composition comprising an active ingredient, in particular an active ingredient for transdermal release of human insulin. Insulin, a hormone that inhibits pancreatic glycogenolysis and lowers blood glucose, is available as the most important pharmaceutical for the treatment of diabetes through the transdermal route of absorption. [Selection] Figure 1 |